Lonza Agrees to Buy Merck’s U.S. Contract Drug Manufacturing Network
Stifel analyst Ed Hall says the acquisition expands Lonza’s U.S. presence and is at a modest valuation. The supplied report truncates before giving the valuation.
Stifel analyst Ed Hall says the acquisition expands Lonza’s U.S. presence and is at a modest valuation. The supplied report truncates before giving the valuation.